Patents Assigned to CanCap Pharmaceutical Ltd.
  • TREATMENT OF BREAST CANCER
    Publication number: 20220313608
    Abstract: The present disclosure provides methods of treating breast cancer, including triple negative breast cancer. The methods disclosed herein comprise administering a cationic liposomal formulation containing one or more cationic lipids and a taxane to a subject in need thereof. The methods also include administering one or more non-liposomal formulations including one or more active agents.
    Type: Application
    Filed: March 21, 2022
    Publication date: October 6, 2022
    Applicants: SynCore Biotechnology Co., Ltd., CanCap Pharmaceutical Ltd.
    Inventors: Sih-Ting Lin, Hsin-Wei Teng, Hui-Yuan Tseng
  • TREATMENT OF BREAST CANCER
    Publication number: 20190015332
    Abstract: The present disclosure provides methods of treating breast cancer, including triple negative breast cancer. The methods disclosed herein comprise administering a cationic liposomal formulation containing one or more cationic lipids and a taxane to a subject in need thereof. The methods also include administering one or more non-liposomal formulations including one or more active agents.
    Type: Application
    Filed: December 28, 2016
    Publication date: January 17, 2019
    Applicants: SynCore Biotechnology Co. Ltd., CanCap Pharmaceutical Ltd.
    Inventors: Sih-Ting Lin, Hsin-Wei Teng, Hui-Yuan Tseng